In CC, we proved for the first time that PGM5-AS1 showed low expression and was an anti-tumor lncRNA in CC by inhibiting proliferation, migration, and invasion, thus enriching the function of PGM5-AS1 in human cancers. Here, PGM5 is linked to cancer.